Exagen Inc. (NASDAQ: XGN) Stock Information | RedChip

Exagen Inc. (NASDAQ: XGN)


$4.2500
+0.3300 ( +7.60% ) 62.3K

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

Market Data


Open


$4.2500

Previous close


$3.9200

Volume


62.3K

Market cap


$73.68M

Day range


$3.7120 - $4.3100

52 week range


$1.3003 - $4.8300

SEC Filings


Form Type Description Pages Date
8-k 8K-related 14 Jan 08, 2024
8-k 8K-related 13 Dec 11, 2023
8-k 8K-related 19 Nov 17, 2023
10-q Quarterly Reports 97 Nov 13, 2023
8-k 8K-related 14 Nov 13, 2023

Latest News